This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow P3Rs: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when P3Rs are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow E-mail this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My File Cabinet
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Baker, J. W.
Right arrow Articles by Walton-Bowen, K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Baker, J. W.
Right arrow Articles by Walton-Bowen, K.
Related Collections
Right arrow Allergy & Dermatology

PEDIATRICS Vol. 103 No. 2 February 1999, pp. 414-421

A Multiple-dosing, Placebo-controlled Study of Budesonide Inhalation Suspension Given Once or Twice Daily for Treatment of Persistent Asthma in Young Children and Infants

Received Feb 23, 1998; accepted Aug 3, 1998.

James W. Baker*, Michael Mellon*, Jeffrey WaldDagger , Michael Welch§, Mario Cruz-Riveraparallel , and Karen Walton-Bowenparallel

From * Kaiser Permanente, San Diego, California; Dagger  Kansas City Allergy and Asthma, Overland Park, Kansas; the § Allergy and Asthma Medical Group and Research Center, San Diego, California; and parallel  Clinical Research, Astra USA, Incorporated, Westborough, Massachusetts.

Rationale.  Topical antiinflammatory medications such as inhaled corticosteroids are recommended for therapy of asthma, but no formulation suitable for administration to infants and young children is available in the United States.

Methods.  This was a 12-week, multicenter, double-blind, randomized, parallel-group study comparing the efficacy and safety of four dosing regimens of bude-sonide inhalation suspension (BIS) or placebo in 480 asthmatic infants and children (64% boys), ages 6 months to 8 years, with moderate persistent asthma. Approximately 30% of children were previously on inhaled corticosteroids that were discontinued before the study. Active treatments were comprised of BIS 0.25 mg once daily (QD), 0.25 mg twice a day (BID), 0.5 mg BID, or 1.0 mg QD. Efficacy was assessed by twice daily recording at home of asthma symptom scores and use of rescue medication, and discontinuation from the study because of worsening asthma and/or a requirement for systemic steroids. Peak flow measurements were recorded twice daily on diary and spirometry was recorded at clinic visits for those children able to perform these tests. Safety was assessed by reported adverse events and by cortisol testing (adrenocorticotropic hormone stimulation) in a subset of patients.

Results.  Patients enrolled had an average duration of asthma of 34 months; the mean asthma symptom score was ~1.3 (scale of 0-3). All dosing regimens with BIS produced statistically significant improvement in various clinical efficacy measures for asthma control compared with placebo. The lowest dose used, 0.25 mg QD, was efficacious but with fewer efficacy parameters than seen with the other doses administered. Separation between active treatment and placebo in daytime and nighttime symptom scores were observed by week 2 of treatment for all BIS treatment regimens. A significant increase in peak flow measurement was observed in most active treatment groups compared with placebo in the subset of children able to do pulmonary function testing. All treatment groups showed numerical improvement in forced expiratory volume in 1 second but only the 0.5-mg BID dose was significantly different from placebo. Adverse events for the entire group and response to adrenocorticotropic hormone in a subgroup of children who underwent cortisol testing before and at the end of the treatment period were no different in budesonide-treated patients in comparison to placebo.

Conclusion.  Results of this study demonstrate that BIS is effective and safe for infants and young children with moderate persistent asthma in a multiple dose range, and that QD dosing is an important option to be considered by the prescribing physician.  Key words:  budesonide, asthma, children, corticosteroids.




This article has been cited by other articles:


Home page
 Eur Respir JHome page
P. L. P. Brand, E. Baraldi, H. Bisgaard, A. L. Boner, J. A. Castro-Rodriguez, A. Custovic, J. de Blic, J. C. de Jongste, E. Eber, M. L. Everard, et al.
Definition, assessment and treatment of wheezing disorders in preschool children: an evidence-based approach
Eur. Respir. J., October 1, 2008; 32(4): 1096 - 1110.
[Abstract] [Full Text] [PDF]

Home page
 CLIN PEDIATRHome page
M. J. Welch
Nebulization Therapy for Asthma: A Practical Guide for the Busy Pediatrician
Clinical Pediatrics, October 1, 2008; 47(8): 744 - 756.
[PDF]

Home page
 NEJMHome page
R. Mangione-Smith, A. H. DeCristofaro, C. M. Setodji, J. Keesey, D. J. Klein, J. L. Adams, M. A. Schuster, and E. A. McGlynn
The Quality of Ambulatory Care Delivered to Children in the United States
N. Engl. J. Med., October 11, 2007; 357(15): 1515 - 1523.
[Abstract] [Full Text] [PDF]

Home page
 The Annals of PharmacotherapyHome page
S. M Gawchik
Successful Treatment of Previously Uncontrolled Adult Asthma with Budesonide Inhalation Suspension: Five-Year Case Histories
Ann. Pharmacother., October 1, 2007; 41(10): 1728 - 1733.
[Abstract] [Full Text] [PDF]

Home page
 Am J Health Syst PharmHome page
C. A. Camargo Jr., S. Ramachandran, K. L. Ryskina, B. E. Lewis, and A. P. Legorreta
Association between common asthma therapies and recurrent asthma exacerbations in children enrolled in a state Medicaid plan
Am. J. Health Syst. Pharm., May 15, 2007; 64(10): 1054 - 1061.
[Abstract] [Full Text] [PDF]

Home page
 PediatricsHome page
R. J. Scarfone, J. J. Zorc, and C. J. Angsuco
Emergency Physicians' Prescribing of Asthma Controller Medications
Pediatrics, March 1, 2006; 117(3): 821 - 827.
[Abstract] [Full Text] [PDF]

Home page
 CMAJHome page
Prevention strategies for asthma -- secondary prevention
Can. Med. Assoc. J., September 13, 2005; 173(6_suppl): S25 - S27.
[Full Text] [PDF]

Home page
 The Annals of PharmacotherapyHome page
J. E McKenzie and M. Cruz-Rivera
Compatibility of Budesonide Inhalation Suspension with Four Nebulizing Solutions
Ann. Pharmacother., June 1, 2004; 38(6): 967 - 972.
[Abstract] [Full Text] [PDF]

Home page
 PediatricsHome page
M. J. Coffey, B. Wilfond, and L. F. Ross
Ethical Assessment of Clinical Asthma Trials Including Children Subjects
Pediatrics, January 1, 2004; 113(1): 87 - 94.
[Abstract] [Full Text] [PDF]

Home page
 PediatricsHome page
K. R. Murphy, S. Fitzpatrick, M. Cruz-Rivera, C. J. Miller, and B. Parasuraman
Effects of Budesonide Inhalation Suspension Compared With Cromolyn Sodium Nebulizer Solution on Health Status and Caregiver Quality of Life in Childhood Asthma
Pediatrics, September 1, 2003; 112(3): e212 - 219.
[Abstract] [Full Text] [PDF]

Home page
 Arch. Dis. Child.Home page
E Verona, D Petrov, E Cserhati, J Hofman, N Geppe, H Medley, and S Hughes
Fluticasone propionate in asthma: a long term dose comparison study
Arch. Dis. Child., June 1, 2003; 88(6): 503 - 509.
[Abstract] [Full Text] [PDF]

Home page
 Arch Pediatr Adolesc MedHome page
P. Lozano, J. A. Finkelstein, J. Hecht, R. Shulruff, and K. B. Weiss
Asthma Medication Use and Disease Burden in Children in a Primary Care Population
Arch Pediatr Adolesc Med, January 1, 2003; 157(1): 81 - 88.
[Abstract] [Full Text] [PDF]

Home page
 Arch. Dis. Child.Home page
D. Radzik and L. Pavanello
Inhaled steroids in the treatment of mild to moderate persistent asthma in children: once or twice daily administration?
Arch. Dis. Child., November 1, 2002; 87(5): 415 - 416.
[Full Text] [PDF]

Home page
 Arch Pediatr Adolesc MedHome page
K. L. Warman, A. M. Jacobs, and E. J. Silver
If We Prescribe It, Will It Come?: Access to Asthma Equipment for Medicaid-Insured Children and Adults in the Bronx, NY
Arch Pediatr Adolesc Med, July 1, 2002; 156(7): 673 - 677.
[Abstract] [Full Text] [PDF]

Home page
 PediatricsHome page
J. G. Leflein, S. J. Szefler, K. R. Murphy, S. Fitzpatrick, M. Cruz-Rivera, C. J. Miller, and J. A. Smith
Nebulized Budesonide Inhalation Suspension Compared With Cromolyn Sodium Nebulizer Solution for Asthma in Young Children: Results of a Randomized Outcomes Trial
Pediatrics, May 1, 2002; 109(5): 866 - 872.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
M. J. VISSER, D. S. POSTMA, L. R. ARENDS, T. W. DE VRIES, E. J. DUIVERMAN, and P. L. P. BRAND
One-Year Treatment with Different Dosing Schedules of Fluticasone Propionate in Childhood Asthma . Effects on Hyperresponsiveness, Lung Function, and Height
Am. J. Respir. Crit. Care Med., December 1, 2001; 164(11): 2073 - 2077.
[Abstract] [Full Text] [PDF]

Home page
 PediatricsHome page
B. Knorr, L. M. Franchi, H. Bisgaard, J. H. Vermeulen, P. LeSouef, N. Santanello, T. M. Michele, T. F. Reiss, H. H. Nguyen, and D. L. Bratton
Montelukast, a Leukotriene Receptor Antagonist, for the Treatment of Persistent Asthma in Children Aged 2 to 5 Years
Pediatrics, September 1, 2001; 108(3): e48 - 48.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
K. G. NIELSEN and H. BISGAARD
The Effect of Inhaled Budesonide on Symptoms, Lung Function, and Cold Air and Methacholine Responsiveness in 2- to 5-year-old Asthmatic Children
Am. J. Respir. Crit. Care Med., October 1, 2000; 162(4): 1500 - 1506.
[Abstract] [Full Text] [PDF]

Home page
 J. Appl. Physiol.Home page
D. Palmer, S. Schurch, and J. Belik
Effect of budesonide and salbutamol on surfactant properties
J Appl Physiol, September 1, 2000; 89(3): 884 - 890.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
M. MELLON, J. LEFLEIN, K. WALTON-BOWEN, M. CRUZ-RIVERA, S. FITZPATRICK, and J. A. SMITH
Comparable Efficacy of Administration with Face Mask or Mouthpiece of Nebulized Budesonide Inhalation Suspension for Infants and Young Children with Persistent Asthma
Am. J. Respir. Crit. Care Med., August 1, 2000; 162(2): 593 - 598.
[Abstract] [Full Text] [PDF]

Home page
 Evid. Based Nurs.Home page
Other Articles Noted
Evid. Based Nurs., October 1, 1999; 2(4): 105 - 112.
[Full Text]

Home page
 JWatch GeneralHome page
New Nebulized Steroid for Treating Young Asthmatics
Journal Watch (General), February 23, 1999; 1999(223): 2 - 2.
[Full Text]